Evidence map›Paper›PMID 35935464›Full record

ReviewSensors international2022

Analytical performances of different diagnostic methods for SARS-CoV-2 virus - A review.

Ravina, Ashok Kumar, Manjeet, Twinkle, Subodh, Jagriti Narang, Hari Mohan

Abstract readReview
In one paragraph

Review in Sensors international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

RavinaCentre for Medical Biotechnology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
Ashok KumarCSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi, 110007, India.
ManjeetCentre for Medical Biotechnology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
TwinkleDCR University of Science and Technology, Murthal, Sonepat, Haryana, 131039, India.
SubodhCentre for Medical Biotechnology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
Jagriti NarangDepartment of Biotechnology, Jamia Hamdard, Delhi, India.
Hari MohanCentre for Medical Biotechnology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Covid-19 is a dreadful pandemic of the 21st century that has created fear among people, affected the whole world, and taken thousands of lives. It infects the respiratory system and causes flu-type symptoms. According to the WHO reports, 2,082,745 deaths and 96,267,473 confirmed cases were perceived all around the globe till January 22, 2021. The significant roots of transmission are inhalation and direct contact with the infected surface. Its incubation period is 2-14 days and remains asymptomatic in most people. However, no treatment and vaccine are available for the people, so preventive measures like social distancing, wearing personal protective equipment (PPE), and frequent hand-washing are the practical and only options for cure. It has affected every sector of the world, whether it is trade or health all around the world. There is high demand for diagnostic tools as high-scale and expeditious testing is crucial for controlling disease spread; thus, detection methods play an essential role. Like flu, Covid-19 is also detected through RT-PCR, as the World Health Organization (WHO) suggested, but it is time taking and expensive method that many countries cannot afford. A vaccine is a crucial aspect of eradicating disease, and for SARS-CoV-2), plasma therapy and antibiotics therapy are used in the early spreading phase. The later stage involves forming a vaccine based on spike protein, N-protein, and whole-viral antigen that effectively immunizes the population worldwide until herd immunity can be achieved. In this review, we will discuss all possible and developed techniques for identifying SARS-CoV-2 and make a comparison of their specificity, selectivity, and cost; thus, we choose an appropriate method for fast, reliable, and pocket-friendly detection.

Indexed as

BiosensorCovid-19Lateral flow immunoassayRT-PCRSARS-CoV-2

Identifiers

PMID35935464
PMCPMC9338831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.